text: One is that the binding of retinoids to nuclear retinoic acid receptors (RARs) does not match their therapeutic efficacy: acitretin activates the three receptor subtypes, RAR-alpha, -beta and -gamma, without measurable receptor binding, whereas << tazarotene >> preferentially binds to and activates RAR-beta and -gamma in preference to [[ RAR-alpha ]].